Home
Mark Andrew Wilson, Chief Legal Officer: Nektar Therapeutics NKTR Sell · Filed 23/02/17
Trade details
- Type
- Insider sale
- Amount
- $24,825
- Shares · price
- 8,275 sh · $3.00 a share
- Held after
- 265,223 sh
- Trade date
- 23/02/16
- Filed
- 23/02/17
- Days to filing
- 1 days
Sold 3.0% of holdings
- Share of holding sold
- 3.0%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 23/01/17~23/03/18Mark Andrew Wilson's recent trades
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$5.7M
78,510 sh
$5.7M
Filed 03/13
Traded 03/13
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$34.2K
630 sh
$34.2K
Filed 25/11/25
Traded 25/11/25
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$37.1K
630 sh
$37.1K
Filed 25/11/25
Traded 25/11/25
- Mark Andrew Wilson
SellNektar Therapeutics
SellNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/21
Traded 25/08/19
- Mark Andrew Wilson
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$18K
676 sh
$18K
Filed 25/08/19
Traded 25/08/19